ConductScience.org, home

Paper33567448

mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants.

Wang Z and 33 others. Nature, 2021. Cited by 1,161 papers, by iCite.

Cite this record

ConductScience Library. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Papers, record 33567448. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33567448

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants.
PubMed
Journal
Nature
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
1,161
iCite
Relative citation ratio, by iCite
59.5
iCite
Revised in PubMed
2026-11-02
PubMed

Authors34

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang ZZijun
2Schmidt FFabian
3Weisblum YYiska
4Muecksch FFraukehttps://orcid.org/0000-0002-0132-5101
5Barnes COChristopher O
6Finkin SShlomohttps://orcid.org/0000-0003-4474-2658
7Schaefer-Babajew DDennishttps://orcid.org/0000-0002-5380-2950
8Cipolla MMelissa
9Gaebler CChristianhttps://orcid.org/0000-0001-7295-8128
10Lieberman JAJenna A
11Oliveira TYThiago Yhttps://orcid.org/0000-0002-2654-0879
12Yang ZZhi
13Abernathy MEMorgan E
14Huey-Tubman KEKathryn E
15Hurley AArlene
16Turroja MMartinahttps://orcid.org/0000-0001-9640-0559
17West KAKamille A
18Gordon KKristie
19Millard KGKatrina Ghttps://orcid.org/0000-0003-2247-3178
20Ramos VVictorhttps://orcid.org/0000-0001-7353-3420

Source PubMed

See all 34 authorsDownload CSV of authors

Topics27

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, ViralMajor topic
COVID-19Major topic
COVID-19 VaccinesMajor topic
SARS-CoV-2Major topic
Spike Glycoprotein, CoronavirusMajor topic
Vaccines, SyntheticMajor topic
2019-nCoV Vaccine mRNA-1273
Adult
Aged
Antibodies, Monoclonal
Antibodies, Neutralizing
B-Lymphocytes
BNT162 Vaccine
Cryoelectron Microscopy
Epitopes, B-Lymphocyte
Female
Humans
Immunization, Secondary
Immunoglobulin G
Immunoglobulin M
Immunologic Memory
Male
Middle Aged
Models, Molecular
Mutation
Neutralization Tests
mRNA Vaccines

Source PubMed

Download CSV of topics

Grants11

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P50 AI150464-13NIH HHSUnited StatesP50AI150464PubMed and NIHNIH RePORTER
Wellcome TrustUnited KingdomPubMedPubMed
P01 AI138938NIAID NIH HHSUnited StatesP01AI138938PubMed and NIHNIH RePORTER
R01 AI78788NIH HHSUnited StatesR01AI078788PubMed and NIHNIH RePORTER
P01 AI138398-S1NIH HHSUnited StatesP01AI138398PubMedNIH RePORTER
Howard Hughes Medical InstituteUnited StatesPubMedPubMed
2U19AI111825NIH HHSUnited StatesU19AI111825PubMed and NIHNIH RePORTER
R37AI064003NIHNIH RePORTER
UL1TR001866NIHNIH RePORTER
ZIAAR041184NIHNIH RePORTER
ZIAAR041211NIHNIH RePORTER

Download CSV of grants

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Update of33501451PubMed
Comment in34023862SARS-CoV-2 mutations, vaccines, and immunity: implication of variants of concern.https://conductscience.org/library/papers/34023862PubMed

Download CSV of comments and corrections

References61

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132425270Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells.Cell2020https://conductscience.org/library/papers/32425270PubMed
233831132A human coronavirus evolves antigenically to escape antibody immunity.PLoS Pathog2021https://conductscience.org/library/papers/33831132PubMed
332698192Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike.Nature2020https://conductscience.org/library/papers/32698192PubMed
430377346A fully automatic method yielding initial models from high-resolution cryo-electron microscopy maps.Nat Methods2018https://conductscience.org/library/papers/30377346PubMed
533592168Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies.Cell Host Microbe2021https://conductscience.org/library/papers/33592168PubMed
633558724Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera.Nat Med2021https://conductscience.org/library/papers/33558724PubMed
733649194Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil.J Virol2021https://conductscience.org/library/papers/33649194PubMed
833332778REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19.N Engl J Med2021https://conductscience.org/library/papers/33332778PubMed
932540902Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability.Science2020https://conductscience.org/library/papers/32540902PubMed
1033404586Genetic Variants of SARS-CoV-2-What Do They Mean?JAMA2021https://conductscience.org/library/papers/33404586PubMed
1133270381Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.N Engl J Med2021https://conductscience.org/library/papers/33270381PubMed
1232805734Structures and distributions of SARS-CoV-2 spike proteins on intact virions.Nature2020https://conductscience.org/library/papers/32805734PubMed
1332555388Convergent antibody responses to SARS-CoV-2 in convalescent individuals.Nature2020https://conductscience.org/library/papers/32555388PubMed
1433112236Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.Elife2020https://conductscience.org/library/papers/33112236PubMed
1533495308Prospective mapping of viral mutations that escape antibodies used to treat COVID-19.Science2021https://conductscience.org/library/papers/33495308PubMed
1623226220Onset of immune senescence defined by unbiased pyrosequencing of human immunoglobulin mRNA repertoires.PLoS One2012https://conductscience.org/library/papers/23226220PubMed
1732722908Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates.N Engl J Med2020https://conductscience.org/library/papers/32722908PubMed
1832692348Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses.J Exp Med2020https://conductscience.org/library/papers/32692348PubMed
1933780970Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma.Nature2021https://conductscience.org/library/papers/33780970PubMed
2032422645Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody.Nature2020https://conductscience.org/library/papers/32422645PubMed

See all 61 referencesDownload CSV of references

Cited by917

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,161 citations.

PMIDTitleJournalYearIn PapersSource
42903912A human monoclonal antibody neutralizes SARS-CoV-2 Omicron variants by targeting the upstream region of spike protein HR2 motif.Hlife2024https://conductscience.org/library/papers/42903912PubMed
42888436The advances and challenges of mRNA-LNP application in fields of hematology and oncology therapeutics.J Hematol Oncol2026https://conductscience.org/library/papers/42888436PubMed
42743315R1-32-like public antibodies acquire tolerance to SARS-CoV-2 antigenic drift through somatic hypermutation.PLoS Biol2026https://conductscience.org/library/papers/42743315PubMed
42497177Broad and durable protection against SARS-CoV-2 and SARS-CoV by an intranasal chimpanzee adenovirus vaccine expressing tandem RBDs and nucleocapsid.PLoS Pathog2026https://conductscience.org/library/papers/42497177PubMed
42479777Environmental drivers of low vaccine responsiveness in a lab-to-wild rodent model.PLoS Pathog2026https://conductscience.org/library/papers/42479777PubMed
42282689A designed overlapping variant immunogen pool elicits broad sarbecovirus neutralization.bioRxiv2026https://conductscience.org/library/papers/42282689PubMed
42189851Utilizing virus genomic surveillance to predict vaccine effectiveness.PLoS Comput Biol2026https://conductscience.org/library/papers/42189851PubMed
42100635High-sensitivity electrochemical immunosensor for anti-SARS-CoV-2 IgG detection using screen-printed carbon/cerium oxide-gold electrode.ADMET DMPK2026https://conductscience.org/library/papers/42100635PubMed
42015414Antibody-antigen neutralization prediction by integrating structural information distillation and physicochemical constraints.Brief Bioinform2026https://conductscience.org/library/papers/42015414PubMed
42014747Impact of timely vaccination and genomic surveillance on controlling consecutive waves of SARS-CoV-2 variants.Sci Rep2026https://conductscience.org/library/papers/42014747PubMed
42009999Safety and efficacy of COVID-19 vaccines in pregnant and lactating women: a comprehensive review.Inflammopharmacology2026https://conductscience.org/library/papers/42009999PubMed
41987210Mechanisms underlying immunodynamics of layered defenses elicited by mRNA vaccination in children.BMC Med2026https://conductscience.org/library/papers/41987210PubMed
41985440Immunological memory to vaccines.Immunity2026https://conductscience.org/library/papers/41985440PubMed
41983390Peripheral vaccination-induced brain-resident memory CD8+ T cells durably protect mice against intracranial malignancy.J Clin Invest2026https://conductscience.org/library/papers/41983390PubMed
41927882AI-aided engineering and production optimization of chimeric hetero-viral capping enzymes for mRNA vaccines.Sci Rep2026https://conductscience.org/library/papers/41927882PubMed
41912532Self-amplifying COVID-19 mRNA vaccination induces longitudinally enhanced antibody function in a Phase 3 trial.NPJ Vaccines2026https://conductscience.org/library/papers/41912532PubMed
41882251Design and immunogenicity evaluation of pan-recombinant vaccines based on the consensus sequence of severe acute respiratory syndrome coronavirus-2 spike protein.Sci Rep2026https://conductscience.org/library/papers/41882251PubMed
41813804DNA origami vaccine nanoparticles improve humoral and cellular immune responses to infectious diseases.Nat Biomed Eng2026https://conductscience.org/library/papers/41813804PubMed
41746934Designing a novel vaccine against COVID-19 based on spike SARS-Cov-2 notable mutations using immunoinformatics approaches.PLoS One2026https://conductscience.org/library/papers/41746934PubMed
41712614Immune-focused RBD nanoparticles induce cross-reactive, RBS-directed responses capable of variant-resistant SARS-CoV-2 neutralization.PLoS Pathog2026https://conductscience.org/library/papers/41712614PubMed

See all 917 cited byDownload CSV of cited by

Genes18

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACE259272PubTator's text mininghttps://conductscience.org/library/genes/59272NCBI Gene
BCR613PubTator's text mininghttps://conductscience.org/library/genes/613NCBI Gene
CBX110951PubTator's text mininghttps://conductscience.org/library/genes/10951NCBI Gene
CD14929PubTator's text mininghttps://conductscience.org/library/genes/929NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
FANCB2187PubTator's text mininghttps://conductscience.org/library/genes/2187NCBI Gene
FCGR3A2214PubTator's text mininghttps://conductscience.org/library/genes/2214NCBI Gene
FURIN5045PubTator's text mininghttps://conductscience.org/library/genes/5045NCBI Gene
IGH3492PubTator's text mininghttps://conductscience.org/library/genes/3492NCBI Gene
IGHV3-5328420PubTator's text mininghttps://conductscience.org/library/genes/28420NCBI Gene
IGHV3-69-128402PubTator's text mininghttps://conductscience.org/library/genes/28402NCBI Gene
IGK50802PubTator's text mininghttps://conductscience.org/library/genes/50802NCBI Gene
IGL3535PubTator's text mininghttps://conductscience.org/library/genes/3535NCBI Gene
IGLV@3546PubTator's text mininghttps://conductscience.org/library/genes/3546NCBI Gene
IL23558PubTator's text mininghttps://conductscience.org/library/genes/3558NCBI Gene
KRT2054474PubTator's text mininghttps://conductscience.org/library/genes/54474NCBI Gene
LOC102723407102723407PubTator's text mininghttps://conductscience.org/library/genes/102723407NCBI Gene
MLC123209PubTator's text mininghttps://conductscience.org/library/genes/23209NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33567448

GET https://conductscience.org/api/papers/v1/33567448/authors?page=2